Porvair to produce materials for filtration and diffusion
BioVyon polymer materials are aimed at pharmaceutical and biotech companies
BioVyon materials are primarily made from polyethylene or polypropylene sintered porous plastic, made by proprietary cGMP processes with low extractable and particle shedding levels. Available in pore sizes from 5 to 100 micron (mean flow pore) the materials are available in sheet, roll, cut shapes or moulded and, depending on the particular specification, have regulatory approvals that meet FDA, WDA and USP requirements.
Porvair Filtration Group has opened a Class 100000 (ISO Class 8) cleanroom at its Wrexham, UK site to produce and package regulatory controlled materials and assembled products in a clean environment.
An ISO 9001-2000 quality assurance programme, cGMP practices and cleanroom environment to ensure products meet the stringent requirements of the life science industries, underpins the manufacture of these specialist high performance products.
You may also like
Packaging
SmartSkin unveils pharma seal assurance solution with real-time insights
Read moreThe breakthrough solution will give manufacturers real-time visibility into container closure integrity and capping performance, with SmartSkin aiming to debut the technology at the upcoming IPSE 4.0 in Barcelona
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Packaging
Embracing sustainable change through labelling choice
Paavo Sillanpää, Senior Manager, Ecosystem Pharma and Healthcare, EMEIA, UPM Adhesive Materials, discusses the latest trends in pharmaceutical packaging and labelling and how producers can embrace future-focused solutions and sustainable options without compromising performance
Packaging
Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe
The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial manufacturing network to meet growing pharmaceutical demand
Packaging
MM Pharma partners with AMD to boost vaccine cold chain safety with TempSight technology
The partnership will integrate AMD's TempSight Time Temperature Indicator technology into vaccine packaging, enhancing supply chain security and ensuring safe delivery of temperature-sensitive pharmaceuticals